The Centre has placed a new purchase order with the Serum Institute of India (SII) for the supply of 10 crore doses of the Oxford-AstraZeneca COVID-19 vaccine, Covishield, each costing Rs 157.50, including GST, according to official sources. The HLL Lifecare Limited, a public sector undertaking, has issued the supply order on behalf of the Union health ministry on March 12 in the name of Prakash Kumar Singh, Director, Government and Regulatory Affairs at the Pune-based SII.
The cost of the 10 crore doses would be borne by the health ministry under the budgetary allocation for the purpose.
The expenditure for the earlier orders of the vaccines was funded through the PM Cares Fund, the sources said.
The cost of the 10 crore doses would be borne by the health ministry under the budgetary allocation for the purpose.
The expenditure for the earlier orders of the vaccines was funded through the PM Cares Fund, the sources said.
India has approved two vaccines against COVID-19 -- Covishield, manufactured by the SII, and the indigenously-developed Covaxin of Bharat Biotech -- for restricted emergency use in the country.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
6 Comments on this Story
 | Crypto currencies25 minutes ago When the whole world is suspending Astra Zeneca vaccine why Govt. Is ordering more in a hurry putting peopleâ s lives at risk? Simply because they get more money before it has to be banned in India too? |
 | Manoj Agarwal3 hours ago with out Modi order would have been placed at @1575 |
 | CK Ranjan3 hours ago Good going. Then when govt. is going to have audit of this public fund? |
